作者:Hongbo Zeng、David B. Belanger、Patrick J. Curran、Gerald W. Shipps、Hua Miao、Jack B. Bracken、M. Arshad Siddiqui、Michael Malkowski、Yan Wang
DOI:10.1016/j.bmcl.2011.07.101
日期:2011.10
A series of substituted imidazo[1,2-a]pyrazin-8-amines were discovered as novel breast tumor kinase (Brk)/protein tyrosine kinase 6 (PTK6) inhibitors. Tool compounds with low-nanomolar Brk inhibition activity, high selectivity towards other kinases and desirable DMPK properties were achieved to enable the exploration of Brk as an oncology target. (C) 2011 Elsevier Ltd. All rights reserved.